Drugs / CG1940/CG8711
last change Sep 2008 re-read 3 minutes ago

CG1940/CG8711

Vaccine

Developed for
prostate cancer
Investigated by
Benaroya Research Institute · Cell Genesys · Sanofi

Trials 1

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00577356 Feb → Sep 2008 prostate cancer Benaroya Research Institute Terminated No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CG1940/CG8711 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00577356 ↗
Modality Vaccine “Immunotherapy allogeneic GM-CSF secreting cellular vaccine” NCT00577356 ↗